Received Aug 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
believed it was called GBS; paralyzed from the waist down; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: believed it was called GBS) (serious criteria GSK medically significant) and acute paraplegia (Verbatim: paralyzed from the waist down) (serious criteria GSK medically significant). The outcome of the guillain barre syndrome and acute paraplegia were not reported. It was unknown if the reporter considered the guillain barre syndrome and acute paraplegia to be related to Shingles vaccine. The company considered the guillain barre syndrome and acute paraplegia to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 04-AUG-2025 This case was reported by the friend of the patient via interactive digital media. The reporters buddy (patient) received the vaccine for this and was almost instantly paralyzed from the waist down. The reporter believed that it was called Guillain-Barre Syndrome (GBS), it was rare, but it happened.; Sender's Comments: A case of Guillain-Barre syndrome and Paraplegia, immediately after receiving Shingles vaccine, in a patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.